Dr Reddys Laboratories RDY
NYSE RDY
$11.88 +0.00 (+0.00%)
As of: Sep 9, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Other Working Capital Changes (2013 - 2019)

Dr Reddys Laboratories (RDY) posted Other Working Capital Changes of -$3.3 million for Q2 2026, down 20.66% on a QoQ basis from -$2.7 million in Q3 2025, and up 13.21% year-over-year from -$2.9 million in Q2 2025.

Analysis

Dr Reddys Laboratories (RDY) Other Working Capital Changes (2013 - 2019) Analysis & Trends

Dr Reddys Laboratories has reported Other Working Capital Changes for 8 years, with the latest figure at -$3.3 million in Q2 2026.

  • On a quarterly basis, Other Working Capital Changes rose 13.21% year-over-year to -$3.3 million in Q2 2026; TTM through Jun 2026 was -$15.0 million, a 4.77% increase from a year earlier, with the FY2026 full-year figure at -$13.0 million, up 13.33% from the prior year.
  • Other Working Capital Changes was -$3.3 million for Q2 2026 at Dr Reddys Laboratories, down from -$2.7 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $93.6 million in Q1 2018, with the low at -$61.4 million in Q2 2016.
  • Average Other Working Capital Changes over 5 years is $10.3 million, with a median of $1.8 million recorded in 2016.
  • The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes slumped 102.52% in 2024, then jumped 47.24% in 2025.
  • Over 5 years, Other Working Capital Changes stood at -$2.4 million in 2022, then sank by 76.89% to -$4.3 million in 2023, then retreated by 21.13% to -$5.2 million in 2024, then surged by 47.24% to -$2.7 million in 2025, then decreased by 20.66% to -$3.3 million in 2026.
  • The last three Other Working Capital Changes figures came in at -$3.3 million (Q2 2026), -$2.7 million (Q3 2025), and -$3.8 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 61.59 Mn
Mar 31, 2019 61.59 Mn
Dec 31, 2018 -6.59 Mn
Dec 31, 2018 -6.59 Mn
Sep 30, 2018 26.28 Mn
Sep 30, 2018 26.28 Mn
Jun 30, 2018 -31.63 Mn
Jun 30, 2018 -31.63 Mn
Mar 31, 2018 93.64 Mn
Mar 31, 2018 93.64 Mn
Dec 31, 2017 -6.32 Mn
Dec 31, 2017 -6.32 Mn
Sep 30, 2017 -11.37 Mn
Sep 30, 2017 -11.37 Mn
Jun 30, 2017 -33.84 Mn
Jun 30, 2017 -33.84 Mn
Mar 31, 2017 87.23 Mn
Mar 31, 2017 87.23 Mn
Dec 31, 2016 13.70 Mn
Dec 31, 2016 13.70 Mn